MAS vs NVCR · P/E 18, rev $7.56B vs rev $357.6M
Masco Corporation (MAS) versus Novocure Ltd (NVCR) — a side-by-side from cached financials, not a winner call.
Masco Corporation (MAS) is a building products & equipment company listed on US.
Novocure Ltd (NVCR) is a medical devices company listed on US.
Latest reported MAS revenue for 2025-12-31 was $7.56B. Net income was $810.0M. Revenue was down 3.4% from 2024-12-31 to 2025-12-31. MAS currently screens at market cap $14.00B and trailing P/E 18.1.
Latest reported NVCR revenue for 2026-06-30 was $357.6M. Net income was -$86.8M. NVCR currently screens at market cap $1.99B.
MAS currently screens at market cap $14.00B and trailing P/E 18.1. NVCR currently screens at market cap $1.99B.
Not investment advice. Open the MAS and NVCR stock pages for the full models.
Not investment advice.